Brooks Laboratories Live BSE/NSE | Brooks Laboratories Fundamenta data | Brooks Laboratories Balance sheet | Brooks Laboratories Quarterly Results | Brooks Laboratories Profit & Loss

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

139.82
N/A
10

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

165.17
N/A
1.46

Chart

Price | P:E | P:BV | EV:EBITDA

Revenue CAGR (%)

10 Years
5 Years
3 Years

2.87
-2.72
7.75

EBITDA CAGR (%)

10 Years
5 Years
3 Years

-
-
-15.18

PAT CAGR (%)

10 Years
5 Years
3 Years

-
-
20.86

P:E (Median)

8 Years
5 Years
3 Years

3.62
-
-

P:BV (Average)

8 Years
5 Years
3 Years

0.81
0.81
0.81

EV:EBITDA (Average)

8 Years
5 Years
3 Years

-12.94
-22.71
-39.62

Quarterly Results

Standalone Figures in Rs. Crores

Description Jun 20 Jun 19 Var% Mar 20 Mar 19 Var% Dec 19 Dec 18 Var% Sep 19 Sep 18 Var%
Net Sales 12 17 -26% 19 15 24% 20 15 32% 14 14 0%
Expenses 13 17 -25% 20 18 12% 21 16 30% 16 16 3%
EBITDA 0 0 - -1 -2 - -1 -1 - -2 -1 -
EBIDTM -2% -1% -4% -16% -5% -6% -14% -11%
Other Income 0 0 57% 0 2 -92% 0 0 -40% 0 0 40%
Interest 1 1 -6% 1 1 24% 1 1 12% 1 1 3%
Depreciation 2 2 26% 2 2 18% 2 2 -4% 2 2 2%
PBT -3 -2 - -3 -2 - -3 -3 - -4 -4 -
Tax 0 1 -100% 13 5 170% -1 -1 - -2 -2 -
PAT -3 -4 - -16 -7 - -3 -2 - -2 -2 -
PATM -23% -22% -85% -46% -14% -14% -13% -14%
EPS -1.17 -1.51 - -6.46 -2.81 - -1.14 -0.87 - -0.76 -0.81 -

Description Jun 20 Jun 19 Var% Mar 20 Mar 19 Var% Dec 19 Dec 18 Var% Sep 19 Sep 18 Var%
Net Sales 0 0 0 0 0 0 0 0 0 0 0 0
Expenses 0 0 0 0 0 0 0 0 0 0 0 0
EBITDA 0 0 0 0 0 0 0 0 0 0 0 0
EBIDTM 0% 0% 0% 0% 0% 0% 0% 0%
Other Income 0 0 0 0 0 0 0 0 0 0 0 0
Interest 0 0 0 0 0 0 0 0 0 0 0 0
Depreciation 0 0 0 0 0 0 0 0 0 0 0 0
PBT 0 0 0 0 0 0 0 0 0 0 0 0
Tax 0 0 0 0 0 0 0 0 0 0 0 0
PAT 0 0 0 0 0 0 0 0 0 0 0 0
PATM 0% 0% 0% 0% 0% 0% 0% 0%
EPS 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0

Annual Results

Standalone Figures in Rs. Crores

Description TTM Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Net Sales 65 70 55 56 58 80 85 85 80 56 53 Net Sales Growth 7% 27% -1% -3% -28% -6% 0% 6% 43% 7% Cost Of Goods Sold 43 47 39 39 37 53 61 59 57 36 0 Gross Profit 22 23 16 16 21 27 25 27 23 20 53 GP Margin 34% 33% 28% 29% 36% 34% 29% 31% 28% 35% 101% Total Expenditure 69 74 63 65 52 69 78 77 70 46 43 Power & Fuel Cost - 3 3 4 2 2 3 3 1 1 1 % Of Sales - 4% 5% 6% 3% 3% 3% 3% 1% 1% 1% Employee Cost - 11 10 10 6 5 4 3 2 3 2 % Of Sales - 16% 18% 17% 11% 6% 4% 3% 2% 5% 5% Manufacturing Exp. - 4 4 4 2 2 2 2 2 1 39 % Of Sales - 6% 7% 7% 3% 3% 3% 2% 2% 2% 74% General & Admin Exp. - 5 4 4 3 3 2 2 2 2 2 % Of Sales - 7% 7% 8% 6% 4% 3% 2% 2% 4% 3% Selling & Distn. Exp. - 1 1 1 2 2 5 7 6 2 0 % Of Sales - 1% 1% 2% 3% 3% 6% 8% 8% 4% 0% Miscellaneous Exp. - 3 3 3 1 2 2 2 0 0 0 % Of Sales - 4% 6% 5% 2% 2% 2% 3% 0% 0% 0% EBITDA -4 -4 -8 -9 5 11 7 9 10 10 9 EBITDA Margin -6% -6% -15% -16% 9% 14% 8% 10% 13% 19% 18% Other Income 0 0 3 0 0 2 2 0 0 1 0 Interest 3 3 3 2 1 1 0 0 0 2 1 Depreciation 7 7 6 6 2 1 1 1 1 1 1 PBT -14 -14 -15 -18 2 11 8 8 10 9 7 Tax 10 11 0 -4 1 0 1 0 2 0 0 Tax Rate -69% -80% 1% 21% 33% 2% 8% 4% 25% 4% 4% PAT -24 -24 -15 -14 2 11 9 7 7 9 7 PAT before Minority Interest -24 -24 -15 -14 2 11 9 7 7 9 7 Minority Interest 0 0 0 0 0 0 0 0 0 0 0 PAT Margin -36% -35% -27% -25% 3% 13% 11% 8% 9% 16% 13% PAT Growth 0% -65% -7% -927% -84% 12% 31% 1% -19% 28% EPS -9.53 -9.87 -6.00 -5.59 0.68 4.30 3.83 2.93 2.89 3.58 2.79

Description

TTM

Mar 20

Mar 19

Mar 18

Mar 17

Mar 16

Mar 15

Mar 14

Mar 13

Mar 12

Mar 11

Net Sales

Net Sales Growth

27%

-1%

-3%

-28%

-6%

43%

Cost Of Goods Sold

Gross Profit

GP Margin

34%

33%

28%

29%

36%

34%

29%

31%

28%

35%

101%

Total Expenditure

Power & Fuel Cost

% Of Sales

Employee Cost

% Of Sales

16%

18%

17%

11%

Manufacturing Exp.

% Of Sales

74%

General & Admin Exp.

% Of Sales

Selling & Distn. Exp.

% Of Sales

Miscellaneous Exp.

% Of Sales

EBITDA

-4

-8

-9

EBITDA Margin

-6%

-15%

-16%

14%

10%

13%

19%

18%

Other Income

Interest

Depreciation

PBT

-14

-15

-18

Tax

-4

Tax Rate

-69%

-80%

21%

33%

25%

PAT

-24

-15

-14

PAT before Minority Interest

-24

-15

-14

Minority Interest

PAT Margin

-36%

-35%

-27%

-25%

13%

11%

16%

13%

PAT Growth

-65%

-7%

-927%

-84%

12%

31%

-19%

28%

EPS

-9.53

-9.87

-6.00

-5.59

0.68

4.30

3.83

2.93

2.89

3.58

2.79

Results Balance Sheet

Standalone Figures in Rs. Crores

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Shareholder's Funds 98 105 114 128 122 111 112 105 91 19 Share Capital 25 16 16 16 16 16 16 16 16 10 Total Reserves 74 83 98 112 106 95 96 89 75 10 Non-Current Liabilities 14 4 7 5 6 2 2 2 2 2 Secured Loans 11 14 17 11 0 0 0 0 0 1 Unsecured Loans 0 0 0 0 0 0 0 0 0 0 Long Term Provisions 2 1 1 2 4 1 1 0 0 0 Current Liabilities 46 47 40 24 28 22 18 24 14 20 Trade Payables 26 27 27 18 16 19 16 13 7 7 Other Current Liabilities 7 5 5 4 6 2 2 3 1 1 Short Term Borrowings 13 14 9 2 5 1 0 1 1 8 Short Term Provisions 1 0 0 0 1 1 0 7 4 4 Total Liabilities 158 157 162 158 156 136 132 132 107 41 Net Block 112 117 124 125 16 16 20 21 22 19 Gross Block 132 132 132 127 23 21 25 24 25 21 Accumulated Depreciation 19 15 8 2 7 6 5 4 3 2 Non Current Assets 120 125 131 136 126 81 74 62 62 24 Capital Work in Progress 1 0 1 0 87 53 37 36 34 1 Non Current Investment 0 0 1 1 0 0 0 0 0 0 Long Term Loans & Adv. 7 7 6 10 23 12 17 6 6 4 Other Non Current Assets 0 0 0 0 0 0 0 0 0 0 Current Assets 38 32 31 22 30 55 55 66 42 17 Current Investments 0 0 0 0 0 0 0 0 0 0 Inventories 14 10 11 8 7 8 6 5 5 6 Sundry Debtors 16 11 10 11 19 19 16 22 11 7 Cash & Bank 2 3 2 2 2 23 30 24 20 1 Other Current Assets 7 6 7 1 2 5 2 15 6 4 Short Term Loans & Adv. 1 1 0 1 2 0 1 7 6 4 Net Current Assets -8 -16 -10 -2 2 33 37 42 28 -3 Total Assets 158 157 162 158 156 136 132 132 107 41

Description

Mar 20

Mar 19

Mar 18

Mar 17

Mar 16

Mar 15

Mar 14

Mar 13

Mar 12

Mar 11

Shareholder's Funds

105

114

128

122

111

112

105

Share Capital

Total Reserves

112

106

Non-Current Liabilities

Secured Loans

Unsecured Loans

Long Term Provisions

Current Liabilities

Trade Payables

Other Current Liabilities

Short Term Borrowings

Short Term Provisions

Total Liabilities

158

157

162

158

156

136

132

107

Net Block

112

117

124

125

Gross Block

132

127

Accumulated Depreciation

Non Current Assets

120

125

131

136

126

Capital Work in Progress

Non Current Investment

Long Term Loans & Adv.

Other Non Current Assets

Current Assets

Current Investments

Inventories

Sundry Debtors

Cash & Bank

Other Current Assets

Short Term Loans & Adv.

Net Current Assets

-8

-16

-10

-2

-3

Total Assets

158

157

162

158

156

136

132

107

Cash Flow

Standalone Figures in Rs. Crores

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Cash From Operating Activity -9 -5 -6 10 8 2 11 5 -1 4 PBT -14 -15 -18 2 11 8 8 10 9 7 Adjustment 12 9 10 3 1 -1 1 1 1 1 Changes in Working Capital -8 1 2 6 2 -4 4 -3 -11 -5 Cash after chg. in Working capital -9 -4 -5 11 14 3 12 8 0 3 Interest Paid 0 0 0 0 0 0 0 0 0 0 Tax Paid 0 -1 -1 -2 -5 -2 -2 -2 0 1 Other Direct Exp. Paid 0 0 0 0 0 0 0 0 0 0 Extra & Other Items 0 0 0 0 0 1 0 0 0 0 Cash From Investing Activity -2 1 -5 -17 -14 -1 -11 -1 -41 -1 Net Fixed Assets 0 1 -6 -17 -36 -12 -2 -1 -37 -1 Net Investments 0 0 0 -1 0 0 0 0 0 0 Others -2 0 0 1 22 11 -9 0 -4 0 Cash from Financing Activity 10 6 12 7 4 0 0 0 61 -3 Net Cash Inflow / Outflow -2 2 1 0 -1 1 0 4 19 0 Opening Cash & Equivalents 2 1 0 0 1 1 0 20 1 1 Closing Cash & Equivalent 0 2 1 0 0 1 1 24 20 1

Description

Mar 20

Mar 19

Mar 18

Mar 17

Mar 16

Mar 15

Mar 14

Mar 13

Mar 12

Mar 11

Cash From Operating Activity

-9

-5

-6

-1

PBT

-14

-15

-18

Adjustment

-1

Changes in Working Capital

-8

-4

-3

-11

-5

Cash after chg. in Working capital

-9

-4

-5

Interest Paid

Tax Paid

-1

-2

-5

-2

Other Direct Exp. Paid

Extra & Other Items

Cash From Investing Activity

-2

-5

-17

-14

-1

-11

-1

-41

-1

Net Fixed Assets

-6

-17

-36

-12

-2

-1

-37

-1

Net Investments

-1

Others

-2

-9

-4

Cash from Financing Activity

-3

Net Cash Inflow / Outflow

-2

-1

Opening Cash & Equivalents

Closing Cash & Equivalent

Financial Ratios

Standalone

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Book Value (Rs.) 40 51 59 66 63 57 56 53 45 16 ROA -15% -9% -9% 1% 7% 7% 5% 6% 12% 18% ROE -25% -14% -11% 1% 9% 9% 7% 8% 16% 42% ROCE -8% -9% -11% 3% 10% 10% 7% 10% 18% 32% Fixed Asset Turnover 0.53 0.42 0.44 0.86 3.61 3.70 3.48 3.26 2.43 2.51 Receivable days 71 72 67 83 87 77 82 74 57 53 Inventory Days 62 71 61 40 32 29 24 23 35 35 Payable days 127 149 121 121 95 84 70 53 58 71 Cash Conversion Cycle 7 -6 7 2 25 22 35 43 34 18 Total Debt/Equity 0.27 0.31 0.24 0.11 0.05 0.00 0.00 0.01 0.01 0.45 Interest Cover -3 -4 -6 3 15 24 65 85 7 6

Description

Mar 20

Mar 19

Mar 18

Mar 17

Mar 16

Mar 15

Mar 14

Mar 13

Mar 12

Mar 11

Book Value (Rs.)

ROA

-15%

-9%

12%

18%

ROE

-25%

-14%

-11%

16%

42%

ROCE

-8%

-9%

-11%

10%

18%

32%

Fixed Asset Turnover

0.53

0.42

0.44

0.86

3.61

3.70

3.48

3.26

2.43

2.51

Receivable days

Inventory Days

Payable days

127

149

121

Cash Conversion Cycle

-6

Total Debt/Equity

0.27

0.31

0.24

0.11

0.05

0.00

0.01

0.45

Interest Cover

-3

-4

-6

Brooks Laboratories Ltd.

Pharmaceuticals & Drugs

BSE: 533543 | NSE: BROOKS

Stock Summary

Chart

Price | P:E | P:BV | EV:EBITDA

Revenue CAGR (%)

EBITDA CAGR (%)

PAT CAGR (%)

P:E (Median)

P:BV (Average)

EV:EBITDA (Average)

Quarterly Results

Standalone Figures in Rs. Crores

Annual Results

Standalone Figures in Rs. Crores

Results Balance Sheet

Standalone Figures in Rs. Crores

Cash Flow

Standalone Figures in Rs. Crores

Financial Ratios

Standalone

Annual Reports:

News Update

Brooks Laboratories Ltd.

Pharmaceuticals & Drugs

BSE: 533543 | NSE: BROOKS

Stock Summary

Shareholding Pattern

Chart

Price | P:E | P:BV | EV:EBITDA

Revenue CAGR (%)

EBITDA CAGR (%)

PAT CAGR (%)

P:E (Median)

P:BV (Average)

EV:EBITDA (Average)

Quarterly Results

Standalone Figures in Rs. Crores

Annual Results

Standalone Figures in Rs. Crores

Results Balance Sheet

Standalone Figures in Rs. Crores

Cash Flow

Standalone Figures in Rs. Crores

Financial Ratios

Standalone

Annual Reports:

News Update